Outpatient Surgery Magazine

Patient Experience - June 2019 - Subscribe to Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://outpatientsurgery.uberflip.com/i/1131499

Contents of this Issue

Navigation

Page 12 of 112

844.446.6979 *For professional use only. ImprimisRx specializes in customizing medications to meet unique patient and practitioner needs. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx does not compound copies of commercially available products. References available upon request. ImprimisRx, Tri-Moxi, Dex-Moxi, Dex-Moxi-Ketor, and MKO Melt are registered trademarks of Harrow Health, Inc. ©2019 ImprimisRx. All rights reserved. IMPO0359 Rev2 05/19 As of 05.13.19 For All Your Surgical Needs From our FDA-Registered Outsourcing Facility Order at: www.order.imprimisrx.com Injectable Formulations* Tri-Moxi® (Triamcinolone acetonide and moxifloxacin hydrochloride) 15mg/1mg/mL Dex-Moxi® (Dexamethasone and moxifloxacin hydrochloride) 1mg/5mg/mL Dex-Moxi-Ketor® (Dexamethasone, moxifloxacin hydrochloride and ketorolac) 1mg/0.5mg/0.4mg/mL Oral Formulations* MKO Melt® (Midazolam, ketamine HCl and ondansetron) (3/25/2) mg Moxifloxacin 5mg/mL and 1mg/mL Hyaluronidase 175 units/mL Lidocaine/ Epinephrine in BSS (PF/SF) (0.75/0.025)% Phenylephrine/Lidocaine (PF/SF) (1.5/1)% Topical Formulations* Povidone Iodine 5% Steroid, Antibiotic, NSAID Steroid, Antibiotic Steroid, NSAID Steroid Mydriatic 2 (Tropicamide and phenylephrine) (1/2.5)% Mydriatic 4 (Tropicamide, proparacaine, phenylephrine and ketorolac) (1/0.5/2.5/0.5)%

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - Patient Experience - June 2019 - Subscribe to Outpatient Surgery Magazine